Montserrat Rabassa1, Raul Zamora-Ros2, Mireia Urpi-Sarda1, Stefania Bandinelli3, Luigi Ferrucci4, Cristina Andres-Lacueva5, Antonio Cherubini6. 1. Biomarkers and Nutrimetabolomics Laboratory, Nutrition and Food Science Department, Catalonian Reference Network on Food Technology (XaRTA), Institute for Research on Nutrition and Food Safety (INSA-UB), Campus Torribera, Pharmacy and Food Sciences Faculty, University of Barcelona, Barcelona, Spain; 2. Biomarkers Group, Nutrition and Metabolism Section, International Agency for Research on Cancer (IARC), Lyon, France; 3. Geriatric Rehabilitation Unit, Azienda Sanitaria Firenze, Florence, Italy; 4. Clinical Research Branch, National Institute on Aging, NIH, Baltimore, MD; and. 5. Biomarkers and Nutrimetabolomics Laboratory, Nutrition and Food Science Department, Catalonian Reference Network on Food Technology (XaRTA), Institute for Research on Nutrition and Food Safety (INSA-UB), Campus Torribera, Pharmacy and Food Sciences Faculty, University of Barcelona, Barcelona, Spain; candres@ub.edu. 6. Geriatrics and Geriatric Emergency Care, Italian National Research Centre on Aging, Ancona, Italy.
Abstract
BACKGROUND: Resveratrol may play a protective role against the frailty syndrome (FS) because of its antioxidant and anti-inflammatory properties. OBJECTIVE: We prospectively evaluated the association between habitual dietary resveratrol exposure and the development of FS after 3-, 6-, and 9-y follow-up periods in a community-dwelling older population. DESIGN: We conducted a longitudinal analysis with the use of data from 769 participants aged ≥65 y from the Invecchiare in Chianti (Aging in Chianti) study. Total dietary resveratrol (TDR) intake was estimated at baseline with the use of a validated food-frequency questionnaire, which was developed to assess participants' usual food intakes over the previous year, and an ad hoc resveratrol database. Total urinary resveratrol (TUR) was analyzed with the use of liquid chromatography-tandem mass spectrometry with a previous solid-phase extraction at baseline. The combination of both measures [total dietary resveratrol plus total urinary resveratrol (TDR+TUR)] was computed with the use of the Howe's method. FS was assessed at baseline and at 3-, 6-, and 9-y of follow-up and was defined as the presence of ≥3 of the following 5 criteria: shrinking, exhaustion, sedentariness, slowness, and weakness. RESULTS: TDR+TUR concentrations were inversely associated with FS risk over 3-y of follow-up (OR for comparison of extreme tertiles: 0.11; 95% CI: 0.03, 0.45; P-trend = 0.002) but not after 6- and 9-y of follow-up in multinomial logistic regression models adjusted for baseline frailty status and potential confounders. These results did not differ when analyses were further adjusted for inflammatory markers. CONCLUSION: Higher habitual dietary resveratrol exposure was associated with lower risk of older community dwellers developing FS during the first 3 y of follow-up but not after longer follow-up periods.
BACKGROUND:Resveratrol may play a protective role against the frailty syndrome (FS) because of its antioxidant and anti-inflammatory properties. OBJECTIVE: We prospectively evaluated the association between habitual dietary resveratrol exposure and the development of FS after 3-, 6-, and 9-y follow-up periods in a community-dwelling older population. DESIGN: We conducted a longitudinal analysis with the use of data from 769 participants aged ≥65 y from the Invecchiare in Chianti (Aging in Chianti) study. Total dietary resveratrol (TDR) intake was estimated at baseline with the use of a validated food-frequency questionnaire, which was developed to assess participants' usual food intakes over the previous year, and an ad hoc resveratrol database. Total urinary resveratrol (TUR) was analyzed with the use of liquid chromatography-tandem mass spectrometry with a previous solid-phase extraction at baseline. The combination of both measures [total dietary resveratrol plus total urinary resveratrol (TDR+TUR)] was computed with the use of the Howe's method. FS was assessed at baseline and at 3-, 6-, and 9-y of follow-up and was defined as the presence of ≥3 of the following 5 criteria: shrinking, exhaustion, sedentariness, slowness, and weakness. RESULTS: TDR+TUR concentrations were inversely associated with FS risk over 3-y of follow-up (OR for comparison of extreme tertiles: 0.11; 95% CI: 0.03, 0.45; P-trend = 0.002) but not after 6- and 9-y of follow-up in multinomial logistic regression models adjusted for baseline frailty status and potential confounders. These results did not differ when analyses were further adjusted for inflammatory markers. CONCLUSION: Higher habitual dietary resveratrol exposure was associated with lower risk of older community dwellers developing FS during the first 3 y of follow-up but not after longer follow-up periods.
Authors: Ying Xu; Zhichao Wang; Wenting You; Xiuhua Zhang; Shan Li; Philip A Barish; Matthew M Vernon; Xia Du; Gaowen Li; Jianchun Pan; William O Ogle Journal: Eur Neuropsychopharmacol Date: 2010-03-30 Impact factor: 4.600
Authors: Kevin J Pearson; Joseph A Baur; Kaitlyn N Lewis; Leonid Peshkin; Nathan L Price; Nazar Labinskyy; William R Swindell; Davida Kamara; Robin K Minor; Evelyn Perez; Hamish A Jamieson; Yongqing Zhang; Stephen R Dunn; Kumar Sharma; Nancy Pleshko; Laura A Woollett; Anna Csiszar; Yuji Ikeno; David Le Couteur; Peter J Elliott; Kevin G Becker; Placido Navas; Donald K Ingram; Norman S Wolf; Zoltan Ungvari; David A Sinclair; Rafael de Cabo Journal: Cell Metab Date: 2008-07-03 Impact factor: 27.287
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Gemma Chiva-Blanch; Mireia Urpi-Sarda; Maria Rotchés-Ribalta; Raul Zamora-Ros; Rafael Llorach; Rosa Maria Lamuela-Raventós; Ramon Estruch; Cristina Andrés-Lacueva Journal: J Chromatogr A Date: 2010-12-13 Impact factor: 4.759
Authors: Richard D Semba; Luigi Ferrucci; Benedetta Bartali; Mireia Urpí-Sarda; Raul Zamora-Ros; Kai Sun; Antonio Cherubini; Stefania Bandinelli; Cristina Andres-Lacueva Journal: JAMA Intern Med Date: 2014-07 Impact factor: 21.873
Authors: Dushani L Palliyaguru; Jacqueline M Moats; Clara Di Germanio; Michel Bernier; Rafael de Cabo Journal: Mech Ageing Dev Date: 2019-03-26 Impact factor: 5.432
Authors: Laura Lorenzo-López; Ana Maseda; Carmen de Labra; Laura Regueiro-Folgueira; José L Rodríguez-Villamil; José C Millán-Calenti Journal: BMC Geriatr Date: 2017-05-15 Impact factor: 3.921